Information with respect to the Company's outstanding warrants is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants Issued November 2022 |
|
|
Warrants Issued
September 2024 |
|
|
Warrants Issued
April 2025 |
|
|
Warrants Issued
December 2025 |
|
Outstanding common stock warrants at March 31, 2026* |
|
|
306,280 |
|
|
|
198,783 |
|
|
|
208,333 |
|
|
|
684,523 |
|
Outstanding pre-funded warrants at March 31, 2026* |
|
|
— |
|
|
|
414,519 |
|
|
|
382,307 |
|
|
|
773,809 |
|
Weighted average exercise price of common stock warrants at March 31, 2026* |
|
$ |
117.90 |
|
|
$ |
15.00 |
|
|
$ |
23.70 |
|
|
$ |
9.00 |
|
Weighted average exercise price of pre-funded warrants at March 31, 2026* |
|
$ |
— |
|
|
$ |
0.030 |
|
|
$ |
0.030 |
|
|
$ |
0.030 |
|
Weighted average contract remaining life (in years) at March 31, 2026 |
|
|
1.62 |
|
|
|
3.50 |
|
|
|
4.05 |
|
|
|
4.72 |
|
(*) Retroactively adjusted to reflect the one-for-thirty (1-for-30) reverse stock split, which was effective on April 23, 2026. See Note 2. |